Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 469

1.

Risk of Cirrhosis and Hepatocellular Cancer in Patients with Non-Alcoholic Fatty Liver Disease and Normal Liver Enzymes.

Natarajan Y, Kramer JR, Yu X, Li L, Thrift AP, El-Serag HB, Kanwal F.

Hepatology. 2020 Feb 5. doi: 10.1002/hep.31157. [Epub ahead of print]

PMID:
32022277
2.

AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review.

Loomba R, Lim JK, Patton H, El-Serag HB.

Gastroenterology. 2020 Jan 29. pii: S0016-5085(20)30127-X. doi: 10.1053/j.gastro.2019.12.053. [Epub ahead of print]

PMID:
32006545
3.

Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans.

Tan MC, Mallepally N, Liu Y, El-Serag HB, Thrift AP.

Am J Gastroenterol. 2020 Jan 3. doi: 10.14309/ajg.0000000000000498. [Epub ahead of print]

PMID:
31899705
4.

Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population.

Choi DT, Puenpatom A, Yu X, Erickson KF, Kanwal F, El-Serag HB, Kramer JR.

Antiviral Res. 2020 Feb;174:104698. doi: 10.1016/j.antiviral.2019.104698. Epub 2019 Dec 17.

PMID:
31862503
5.

AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia.

Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S, Falck-Ytter Y, Mustafa RA.

Gastroenterology. 2020 Feb;158(3):693-702. doi: 10.1053/j.gastro.2019.12.003. Epub 2019 Dec 6. No abstract available.

PMID:
31816298
6.

Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.

Ayyagari S, Tan MC, Liu Y, El-Serag HB, Thrift AP.

Dig Dis Sci. 2019 Dec 4. doi: 10.1007/s10620-019-05984-x. [Epub ahead of print]

PMID:
31802383
7.

Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population.

Nguyen TH, Mallepally N, Hammad T, Liu Y, Thrift AP, El-Serag HB, Tan MC.

Dig Dis Sci. 2019 Nov 14. doi: 10.1007/s10620-019-05955-2. [Epub ahead of print]

PMID:
31728790
8.

The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease.

Thakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK.

Inflamm Bowel Dis. 2019 Nov 15. pii: izz280. doi: 10.1093/ibd/izz280. [Epub ahead of print]

PMID:
31728520
9.

Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.

Zhang X, El-Serag HB, Thrift AP.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):88-94. doi: 10.1158/1055-9965.EPI-19-1052. Epub 2019 Nov 11.

PMID:
31712271
10.

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non-alcoholic Fatty Liver Disease.

Kanwal F, Kramer J, Li L, Dai J, Natarajan Y, Yu X, Asch SM, El-Serag HB.

Hepatology. 2019 Nov 1. doi: 10.1002/hep.31014. [Epub ahead of print]

PMID:
31675427
11.

Durability and Effectiveness of Cognitive-Behavioral Therapy for Irritable Bowel Syndrome.

Shapiro J, El-Serag HB, Chan J.

Gastroenterology. 2019 Dec;157(6):1684-1686. doi: 10.1053/j.gastro.2019.10.010. Epub 2019 Oct 12. No abstract available.

PMID:
31614122
12.

Reply to: "Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma".

Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, La Vecchia C, Negri E.

J Hepatol. 2019 Dec;71(6):1262-1263. doi: 10.1016/j.jhep.2019.08.033. Epub 2019 Sep 26. No abstract available.

13.

Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.

Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB.

Cancer. 2019 Dec 1;125(23):4210-4223. doi: 10.1002/cncr.32444. Epub 2019 Sep 6.

PMID:
31490550
14.

Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1.

Shobassy M, Husainat N, Tabash A, Patel K, El-Serag HB, Othman MO.

Gastroenterol Res Pract. 2019 Aug 14;2019:5290642. doi: 10.1155/2019/5290642. eCollection 2019.

15.

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.

Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson LA, Llovet JM, Finn RS, Groopman JD, El-Serag HB, Monga SP, Wang XW, Karin M, Schwartz RE, Tanabe KK, Roberts LR, Gunaratne PH, Tsung A, Brown KA, Lawrence TS, Salem R, Singal AG, Kim AK, Rabiee A, Resar L, Hoshida Y, He AR, Ghoshal K, Ryan PB, Jaffee EM, Guha C, Mishra L, Coleman CN, Ahmed MM.

Cancer Res. 2019 Sep 1;79(17):4326-4330. doi: 10.1158/0008-5472.CAN-19-0803. Erratum in: Cancer Res. 2019 Nov 15;79(22):5897.

16.

Helicobacter pylori Infection.

Graham DY, Dang BN, El-Serag HB.

N Engl J Med. 2019 Aug 8;381(6):587-588. doi: 10.1056/NEJMc1905439. No abstract available.

PMID:
31390511
17.

Burden of Gastric Cancer.

Thrift AP, El-Serag HB.

Clin Gastroenterol Hepatol. 2020 Mar;18(3):534-542. doi: 10.1016/j.cgh.2019.07.045. Epub 2019 Jul 27. Review.

PMID:
31362118
18.

Dietary quality and the colonic mucosa-associated gut microbiome in humans.

Liu Y, Ajami NJ, El-Serag HB, Hair C, Graham DY, White DL, Chen L, Wang Z, Plew S, Kramer J, Cole R, Hernaez R, Hou J, Husain N, Jarbrink-Sehgal ME, Kanwal F, Ketwaroo G, Natarajan Y, Shah R, Velez M, Mallepally N, Petrosino JF, Jiao L.

Am J Clin Nutr. 2019 Sep 1;110(3):701-712. doi: 10.1093/ajcn/nqz139.

PMID:
31291462
19.

Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents.

Kanwal F, Kramer JR, Asch SM, Cao Y, Li L, El-Serag HB.

Hepatology. 2020 Jan;71(1):44-55. doi: 10.1002/hep.30823. Epub 2019 Aug 19.

PMID:
31222774
20.

Prospective implementation of algorithmic patient selection for gastrostomy tube placement consultations: a pre- and post-intervention analysis.

Cano JJ, Thrift AP, El-Serag HB.

Clin Exp Gastroenterol. 2019 May 30;12:231-237. doi: 10.2147/CEG.S197122. eCollection 2019.

21.

Recommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care.

Shapiro JM, El-Serag HB, Gandle C, Peacock C, Denson LA, Fishman LN, Hernaez R, Hou JK.

Clin Gastroenterol Hepatol. 2020 Feb;18(2):276-289.e2. doi: 10.1016/j.cgh.2019.04.063. Epub 2019 May 8. Review.

PMID:
31077824
22.

Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.

Zou WY, Choi K, Kramer JR, Yu X, Cao Y, El-Serag HB, Kanwal F.

Dig Dis Sci. 2019 Nov;64(11):3328-3336. doi: 10.1007/s10620-019-05641-3. Epub 2019 Apr 30.

PMID:
31041639
23.

The Epidemiology of Hepatocellular Carcinoma in the USA.

Kim HS, El-Serag HB.

Curr Gastroenterol Rep. 2019 Apr 11;21(4):17. doi: 10.1007/s11894-019-0681-x. Review.

PMID:
30976932
24.

Gastric Microbiota in Helicobacter pylori-Negative and -Positive Gastritis Among High Incidence of Gastric Cancer Area.

Gantuya B, El-Serag HB, Matsumoto T, Ajami NJ, Oyuntsetseg K, Azzaya D, Uchida T, Yamaoka Y.

Cancers (Basel). 2019 Apr 10;11(4). pii: E504. doi: 10.3390/cancers11040504.

25.

The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection.

El-Serag HB, Christie IC, Puenpatom A, Castillo D, Kanwal F, Kramer JR.

Aliment Pharmacol Ther. 2019 Jun;49(11):1442-1447. doi: 10.1111/apt.15240. Epub 2019 Apr 1.

PMID:
30932218
26.

Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.

Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, La Vecchia C, Negri E.

J Hepatol. 2019 Jul;71(1):104-114. doi: 10.1016/j.jhep.2019.03.013. Epub 2019 Mar 23.

PMID:
30910538
27.

Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon.

Gurwara S, Ajami NJ, Jang A, Hessel FC, Chen L, Plew S, Wang Z, Graham DY, Hair C, White DL, Kramer J, Kourkoumpetis T, Hoffman K, Cole R, Hou J, Husain N, Jarbrink-Sehgal M, Hernaez R, Kanwal F, Ketwaroo G, Shah R, Velez M, Natarajan Y, El-Serag HB, Petrosino JF, Jiao L.

Nutrients. 2019 Mar 13;11(3). pii: E613. doi: 10.3390/nu11030613.

28.

A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women.

Jiao L, Maity S, Coarfa C, Rajapakshe K, Chen L, Jin F, Putluri V, Tinker LF, Mo Q, Chen F, Sen S, Sangi-Hyghpeykar H, El-Serag HB, Putluri N.

Cancer Prev Res (Phila). 2019 Apr;12(4):237-246. doi: 10.1158/1940-6207.CAPR-18-0201. Epub 2019 Feb 5.

PMID:
30723176
29.

Reply.

El-Serag HB, Graham DY.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1420. doi: 10.1016/j.cgh.2019.01.039. Epub 2019 Jan 30. No abstract available.

PMID:
30710706
30.

Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study.

Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, Beretta L, Ning J, El-Serag HB.

Am J Gastroenterol. 2019 Mar;114(3):530-532. doi: 10.14309/ajg.0000000000000068.

PMID:
30699099
31.

Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization.

Tansel A, Kramer J, Feng H, El-Serag HB, Kanwal F.

Dig Dis Sci. 2019 Jun;64(6):1470-1477. doi: 10.1007/s10620-019-5459-3. Epub 2019 Jan 23.

PMID:
30673983
32.

Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285].

Hsu YC, Yip TC, Ho HJ, Wong VW, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GL, Wu CY.

J Hepatol. 2019 Mar;70(3):581. doi: 10.1016/j.jhep.2018.12.010. Epub 2019 Jan 8. No abstract available.

PMID:
30635242
33.

Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey.

Kim HS, Yang JD, El-Serag HB, Kanwal F.

J Viral Hepat. 2019 May;26(5):596-602. doi: 10.1111/jvh.13060. Epub 2019 Mar 13.

PMID:
30629790
34.

Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.

Thrift AP, Natarajan Y, Liu Y, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2117-2125.e3. doi: 10.1016/j.cgh.2018.12.046. Epub 2019 Jan 6.

PMID:
30625400
35.

Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma.

Sparkman J, Hernaez R, El-Serag HB.

Transl Gastroenterol Hepatol. 2018 Nov 26;3:97. doi: 10.21037/tgh.2018.11.05. eCollection 2018. No abstract available.

36.

Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.

Hernaez R, Kramer JR, Liu Y, Tansel A, Natarajan Y, Hussain KB, Ginès P, Solà E, Moreau R, Gerbes A, El-Serag HB, Kanwal F.

J Hepatol. 2019 Apr;70(4):639-647. doi: 10.1016/j.jhep.2018.12.018. Epub 2018 Dec 25.

PMID:
30590100
37.

Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.

Tayob N, Christie I, Richardson P, Feng Z, White DL, Davila J, Corley DA, Kanwal F, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1886-1893.e5. doi: 10.1016/j.cgh.2018.12.005. Epub 2018 Dec 14.

PMID:
30557738
38.

Changing Trends in Colorectal Cancers (Detected by Screening, During Screening Intervals, or Associated With Nonadherence) Identify Possible Health Care System Quality Measures.

Tau A, Bernica J, Thrift AP, El-Serag HB.

Gastroenterology. 2019 Feb;156(3):809-811. doi: 10.1053/j.gastro.2018.10.035. Epub 2018 Oct 25. No abstract available.

PMID:
30514636
39.

Reply.

El-Serag HB, Graham DY.

Clin Gastroenterol Hepatol. 2018 Dec;16(12):2005-2006. doi: 10.1016/j.cgh.2018.08.035. No abstract available.

40.

Reply.

El-Serag HB, Graham DY.

Clin Gastroenterol Hepatol. 2018 Dec;16(12):2004. doi: 10.1016/j.cgh.2018.08.031. No abstract available.

41.

Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.

Hammad TA, Thrift AP, El-Serag HB, Husain NS.

Dig Dis Sci. 2019 Feb;64(2):367-372. doi: 10.1007/s10620-018-5336-5. Epub 2018 Oct 28.

42.

Epidemiology and Management of Hepatocellular Carcinoma.

Kulik L, El-Serag HB.

Gastroenterology. 2019 Jan;156(2):477-491.e1. doi: 10.1053/j.gastro.2018.08.065. Epub 2018 Oct 24. Review.

43.

Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection.

Thrift AP, Liu Y, Tsavachidis S, White DL, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1912-1914. doi: 10.1016/j.cgh.2018.10.024. Epub 2018 Oct 18.

PMID:
30342914
44.

Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin.

Husain NS, El-Serag HB.

Nat Rev Clin Oncol. 2018 Dec;15(12):728-730. doi: 10.1038/s41571-018-0096-x. No abstract available.

PMID:
30237519
45.

Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.

Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, Li L, Desiderio R, Thrift AP, Asch SM, Chu J, El-Serag HB.

Gastroenterology. 2018 Dec;155(6):1828-1837.e2. doi: 10.1053/j.gastro.2018.08.024. Epub 2018 Aug 23.

46.

Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival.

Wenker TN, Tan MC, Liu Y, El-Serag HB, Thrift AP.

Dig Dis Sci. 2018 Nov;63(11):3112-3119. doi: 10.1007/s10620-018-5241-y. Epub 2018 Aug 14.

47.

Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis.

Nguyen P, Valanejad L, Cast A, Wright M, Garcia JM, El-Serag HB, Karns R, Timchenko NA.

Cell Rep. 2018 Aug 7;24(6):1597-1609. doi: 10.1016/j.celrep.2018.07.014.

48.

Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels.

El-Serag HB.

Gastroenterology. 2018 Sep;155(3):607-609. doi: 10.1053/j.gastro.2018.07.036. Epub 2018 Aug 1. No abstract available.

49.

Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women's Health Initiative Study.

Wang Z, White DL, Hoogeveen R, Chen L, Whitsel EA, Richardson PA, Virani SS, Garcia JM, El-Serag HB, Jiao L.

J Clin Med. 2018 Aug 2;7(8). pii: E197. doi: 10.3390/jcm7080197.

50.

Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study.

Dong J, Gu X, El-Serag HB, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):657-665.e13. doi: 10.1016/j.cgh.2018.07.018. Epub 2018 Jul 20.

PMID:
30036643

Supplemental Content

Loading ...
Support Center